Bromocriptine and dopaminergic function in Huntington disease

The cerebrospinal fluid (CSF) content of homovanillic acid (HVA) was assayed in 10 patients with Huntington disease. On doses of less than 40 mg of bromocriptine daily, there was clinical improvement and the CSF HVA concentration increased. On higher doses of bromocriptine, chorea worsened and the CSF HVA concentration decreased. Bromocriptine at low dosage seems to act as a partial dopamine antagonist, with phenothiazine-like effects, and at higher doses it acts as a direct dopamine-receptor stimulating agent.

[1]  E. Tolosa,et al.  The dopaminergic and antidopaminergic effects of some aporphines , 1977, Experimental Neurology.

[2]  D. Calne.  Developments in the pharmacology and therapeutics of parkinsonism , 1977, Annals of neurology.

[3]  G. Di Chiara,et al.  Bromocriptine: a rather specific stimulant of dopamine receptors regulating dopamine metabolism. , 1977, Advances in biochemical psychopharmacology.

[4]  D. Calne,et al.  Bromocriptine in Huntington chorea. , 1976, Archives of neurology.

[5]  A. Dray,et al.  Bromocriptine and dopamine‐receptor stimulation , 1976, The Journal of pharmacy and pharmacology.

[6]  I. Shoulson,et al.  Studies with bromocriptine Part 2. Double‐blind comparison with levodopa in idiopathic parkinsonism , 1976, Neurology.

[7]  K. Fuxe,et al.  The antiparkinsonian efficacy of bromocriptine , 1976, Neurology.

[8]  C. Marsden,et al.  Bromocriptine treatment in Parkinson's disease. , 1976, Journal of neurology, neurosurgery, and psychiatry.

[9]  J. Gerlach,et al.  EFFECT of CB 154 (2‐BROMO‐ALPHA‐ERGOCRYPTINE) ON PARALYSIS AGITANS COMPARED WITH MADOPAR IN A DOUBLE‐BLIND, CROSS‐OVER TRIAL , 1976, Acta neurologica Scandinavica.

[10]  A. M. Johnson,et al.  STIMULANT PROPERTIES OF BROMOCRIPTINE ON CENTRAL DOPAMINE RECEPTORS IN COMPARISON TO APOMORPHINE, (+)‐AMPHETAMINE AND l‐DOPA , 1976, British journal of pharmacology.

[11]  P. Leigh,et al.  IDIOPATHIC PARKINSONISM TREATED WITH BROMOCREPTINE , 1975, The Lancet.

[12]  D. Calne,et al.  Bromocriptine in Parkinsonism , 1974, British medical journal.

[13]  E. Tolosa,et al.  Apomorphine in Huntington's chorea: clinical observations and theoretical considerations. , 1974, Life sciences.

[14]  E. Tolosa.  Paradoxical Suppression of Chorea by Apomorphine , 1974 .

[15]  T. Hökfelt,et al.  Ergocornine and 2-Br-alpha-ergocryptine. Evidence for prolonged dopamine receptor stimulation. , 1974, Medical biology.

[16]  I. van der Veen,et al.  Fluorometric determination of homovanillic acid in biological material after isolation on Sephadex G-10. , 1971, Analytical biochemistry.

[17]  J. Korf,et al.  Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid. , 1971, Biochemical pharmacology.

[18]  B. Roos.  Decrease in homovanillic acid as evidence for dopamine receptor stimulation by apomorphine in the neostriatum of the rat , 1969, The Journal of pharmacy and pharmacology.